As Align Technology INC (ALGN) Shares Rose, Columbia Wanger Asset Management LLC Trimmed Its Position

January 19, 2018 - By Ellis Scott

Investors sentiment decreased to 0.93 in Q3 2017. Its down 0.46, from 1.39 in 2017Q2. It turned negative, as 36 investors sold ALGN shares while 194 reduced holdings. 77 funds opened positions while 137 raised stakes. 62.92 million shares or 1.48% more from 62.01 million shares in 2017Q2 were reported. De Burlo Gp Inc accumulated 85,750 shares. The Pennsylvania-based Smithfield Trust has invested 0.01% in Align Technology, Inc. (NASDAQ:ALGN). Great West Life Assurance Co Can stated it has 0.03% in Align Technology, Inc. (NASDAQ:ALGN). Congress Asset Mngmt Ma has invested 0.14% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). Melvin Mngmt Limited Partnership reported 0.45% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN). National Bank & Trust Of America Corporation De has 0.04% invested in Align Technology, Inc. (NASDAQ:ALGN). Los Angeles Mgmt And Equity Rech reported 0.09% in Align Technology, Inc. (NASDAQ:ALGN). The Connecticut-based Columbus Circle has invested 0.4% in Align Technology, Inc. (NASDAQ:ALGN). Guardian Life Communication Of America accumulated 170 shares or 0% of the stock. Parsons Management Ri has invested 0.05% in Align Technology, Inc. (NASDAQ:ALGN). 1,125 are owned by Koch Industries Inc. Dupont Cap holds 0.02% of its portfolio in Align Technology, Inc. (NASDAQ:ALGN) for 4,377 shares. Comerica Financial Bank reported 0.05% stake. Pittenger Anderson owns 23 shares or 0% of their US portfolio. First Allied Advisory Ser holds 0.01% or 1,711 shares.

Columbia Wanger Asset Management Llc decreased its stake in Align Technology Inc (ALGN) by 15.56% based on its latest 2017Q3 regulatory filing with the SEC. Columbia Wanger Asset Management Llc sold 117,523 shares as the company’s stock rose 36.03% with the market. The institutional investor held 637,971 shares of the health care company at the end of 2017Q3, valued at $118.84 million, down from 755,494 at the end of the previous reported quarter. Columbia Wanger Asset Management Llc who had been investing in Align Technology Inc for a number of months, seems to be less bullish one the $21.70 billion market cap company. The stock decreased 0.57% or $1.55 during the last trading session, reaching $270.7. About 1.09 million shares traded. Align Technology, Inc. (NASDAQ:ALGN) has risen 82.22% since January 19, 2017 and is uptrending. It has outperformed by 65.52% the S&P500.

Columbia Wanger Asset Management Llc, which manages about $39.78B and $6.76 billion US Long portfolio, upped its stake in Svb Financial Group (NASDAQ:SIVB) by 135,770 shares to 324,077 shares, valued at $60.63 million in 2017Q3, according to the filing. It also increased its holding in Seattle Genetics Inc (NASDAQ:SGEN) by 191,180 shares in the quarter, for a total of 605,174 shares, and has risen its stake in Agios Pharmaceuticals Inc (NASDAQ:AGIO).

Analysts await Align Technology, Inc. (NASDAQ:ALGN) to report earnings on January, 30. They expect $0.96 earnings per share, up 43.28 % or $0.29 from last year’s $0.67 per share. ALGN’s profit will be $76.97M for 70.49 P/E if the $0.96 EPS becomes a reality. After $1.01 actual earnings per share reported by Align Technology, Inc. for the previous quarter, Wall Street now forecasts -4.95 % negative EPS growth.

More important recent Align Technology, Inc. (NASDAQ:ALGN) news were published by: Benzinga.com which released: “Jim Cramer Gives His Opinion On Align Technology And Monsanto” on January 03, 2018, also Marketwired.com published article titled: “Align Technology to Announce Fourth Quarter and Fiscal Year 2017 Results on …”, Zacks.com published: “Can Invisalign Drive Align Technology’s (ALGN) Q4 Earnings?” on January 19, 2018. More interesting news about Align Technology, Inc. (NASDAQ:ALGN) was released by: Nasdaq.com and their article: “First Week of February 2018 Options Trading For Align Technology (ALGN)” with publication date: December 20, 2017.

Align Technology, Inc. (NASDAQ:ALGN) Ratings Coverage

Among 12 analysts covering Align Technology (NASDAQ:ALGN), 11 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Align Technology has $290.0 highest and $72 lowest target. $219.64’s average target is -18.86% below currents $270.7 stock price. Align Technology had 47 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Align Technology, Inc. (NASDAQ:ALGN) earned “Buy” rating by Bank of America on Friday, July 28. The stock of Align Technology, Inc. (NASDAQ:ALGN) has “Buy” rating given on Wednesday, March 23 by Roth Capital. The company was maintained on Wednesday, October 18 by Robert W. Baird. Stifel Nicolaus maintained the shares of ALGN in report on Friday, October 23 with “Buy” rating. The stock has “Buy” rating by Leerink Swann on Monday, December 4. As per Friday, October 27, the company rating was maintained by Piper Jaffray. The firm has “Outperform” rating given on Friday, July 28 by Leerink Swann. The firm earned “Outperform” rating on Friday, October 27 by Credit Suisse. The stock of Align Technology, Inc. (NASDAQ:ALGN) earned “Overweight” rating by Piper Jaffray on Wednesday, November 18. Stifel Nicolaus maintained Align Technology, Inc. (NASDAQ:ALGN) rating on Monday, September 11. Stifel Nicolaus has “Buy” rating and $205.0 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.